Все публикации

Impact of national screening program on the elective AAA repair rate & RAAA incidence in population

CX Aortic Vienna: Advance registration ends in 1 week!

Introduction to CX Aortic Vienna 2022

Shape Memory Polymer addresses an “unmet need” for EVAR

APDVS president reflects on COVID-19 training challenges, supply and demand conundrum of the future

Disruptive technology and high-quality clinical evidence: An Endologix transformation

Shockwave IVL: Maintaining options for patients with calcified PAD

Shockwave IVL: Seeing is believing

CX 2022: Choose to attend in-person or virtually

CX 2022: Nick Inston on Vascular Access Challenge

CX 2022: Haulon, Mastracci and Kölbel on Aortic Challenges

CX Aortic Vienna 2021: Watch the key pivotal discussions on-demand! Day 2 Highlights

Future training of aortic surgeons with Dr Eric Roselli

The balance of open and endovascularaortic care with Dr Gustavo Oderich

Edited Cases and the Latest Technology Showcased at CX Aortic Vienna 2021

CX Aortic Vienna 2021: A Conversation with Dr. Joseph Coselli

CX Aortic Vienna 2021 - What To Expect

Vascular Trauma Controversies at CX 2021

The Hurting Leg session: 'Unacceptably high' major amputation rates and the effects of COVID

Lively debates will tackle the biggest controversies in Abdominal Aortic session

Paclitaxel controversy and Podium 1st presentations take centre stage in Peripheral session

COVID-19 and how it affects the global vascular community

CX 2019: Statistical review of methodology and legitimacy of results

Patient-level data from the IN.PACT Clinical Programme: Is paclitaxel safe for treatment of PAD?

welcome to shbcf.ru